The SAFE Fund invests a majority of the funds under management utilizing StockDiagnostics™, a proprietary software product created with an investment of over 22 million dollars and over eight years of development. This software monitors over 1,800 stock data points of more than 16,000 publicly traded companies - 24 hours a day 365 days a year! StockDiagnostics™ begins it's diagnostic review of a company financials by focusing strongly on "cash flow. "While EPS (earnings per share) can be manipulated, cash is difficult if not impossible to fake - you either have it or you don't! StockDiagnostics™ takes the traditional CPS (cash flow per share) and brings it one step further.

OPS (Operational Cash flow per share) which is a term specific to StockDiagnostics™, monitors cash secured from "core business operations only." This metric gives a good look at the health of a company based upon the main business they operate. This ensures we are not looking at cash derived from non-business activities such as inventory or the sale of an asset. We believe "OPS" reveals the true health of a company. StockDiagnostics™ goes on to evaluate and compare the OPS and datapoints using extensive algorithms to determine the strongest companies in the Large, Mid and Small Cap sectors. Up to 100 companies are identified for the large and mid cap sectors, and up to 50 companies in small cap. This gives us almost 250 companies that are considered "the best of the best" based upon the fundamental truth of cash.

The SAFE Fund utlilizes FOLIOfn™, featuring its patented, state-of-the-art Folio trading capability, as well as execution, clearance and settlement services, which permits investors to create, buy, modify and sell portfolios across a variety of securities (such as those identified by StockDiagnostics) in a single transaction enabling the unique ability to own fractional shares. The SAFE Fund, along with the technology of FOLIOfn™ and StockDiagnostics™, believes it can realize the diversification associated with mutual funds without incurring the excessive fees associated with most funds. FOLIOfn™ is a company founded in 1998 by Steven Wallman, the former SEC commissioner.